Today: January 24, 2018, 6:55 am
  
Business

Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference

PR-Inside.com: 2018-01-03 22:06:02

DUBLIN, Ireland, Jan. 3, 2018 - Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan categories, today announced that members of its senior management team will present and participate in the 36th Annual J.P. Morgan Healthcare Conference on January 10th at 8:30 AM PT in San Francisco, CA. 

A live webcast of the company presentation can be accessed through the Investors section of the Company's website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company's website for at least 90 days following the presentation date.

About Prothena

Prothena Corporation plc is a global, late-stage clinical biotechnology company establishing fully integrated research, development and commercial capabilities and focused on advancing new therapies in the neuroscience and orphan categories. Fueled by its deep scientific understanding built over decades of research in protein misfolding, Prothena seeks to fundamentally change the course of grave or currently untreatable diseases associated with this biology. Prothena's pipeline of antibody therapeutic candidates targets a number of indications including AL amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002/RG7935) and ATTR amyloidosis (PRX004). The Company continues discovery of additional novel therapeutic candidates where its deep scientific understanding of disease pathology can be leveraged. For more information, please visit the Company's website at www.prothena.com.

Media & Investor Contact:

Ellen Rose, Head of Communications

650-922-2405, ellen.rose@prothena.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via Globenewswire




# 403 Words
Related Articles
More From The Author
Celebrate the Year of the Dog at [..]
Players at Australia’s favourite online casino, FairGoCasino.com : 2018 is the Year of the Dog, and Fu Chi : The [..]
Aptean Expands Text Analytics Capabilities With TheySay [..]
ALPHARETTA, Ga., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Aptean, a leading global provider of mission-critical enterprise software solutions, [..]
United States Aircraft Insurance Group (USAIG) Celebrates [..]
New York, NY, Jan. 03, 2018 (GLOBE NEWSWIRE) -- On July 1, 2018 USAIG will mark 90 years as a [..]
Microglue of Mexico SRL to become Valco [..]
Valco Melton recently announced that as of December 1, 2017 its Mexico office, formerly known as Microglue de Mexico, made [..]
Bombardier to Provide 54 Additional TWINDEXX Vario [..]
Bombardier Transportation / Bombardier to Provide 54 Additional TWINDEXX Vario Double-Deck Coaches to Israel Railways . Processed [..]
 
More From Business
Keystone Products Used At Commonwealth Law Courts, [..]
Keystone products have been recently used at the Commonwealth Law Courts, Canberra ACT. Installed by Base Joinery, a boutique cabinetmaking [..]
UMS Holdings Acquires 29.5% Stake in Catalist-Listed [..]
SINGAPORE, Jan 23, 2018 - (ACN Newswire) - SGX Mainboard-listed UMS Holdings Limited ("UMS" or "The Group") has [..]
Bhiraj Office REIT (BOFFICE) began SET trading [..]
BANGKOK, Jan 23, 2018 - (ACN Newswire) - Bhiraj Office Leasehold REIT, or SET: BOFFICE, opened for trading on the [..]
Celebrate Each Day of this Valentine’s Week [..]
New Delhi, India: The beautiful celebration of Valentine’s week is upon us. With less than a month to go, it [..]
Hong Kong Fashion Week for Fall/Winter Closes
HONG KONG, Jan 18, 2018 - (ACN Newswire) - Organised by the Hong Kong Trade Development Council (HKTDC), the 49th [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.